| 1. |
- Brandt, J. R., et al.
(författare)
-
Liv og død i Hierapolis. Norske utgravninger i en hellenistisk–romersk–bysantinsk by i Lilleasia
- 2016
-
Ingår i: Viking. - : University of Oslo Library. - 0332-608X .- 2535-2660. ; 79, s. 193-220
-
Tidskriftsartikel (refereegranskat)abstract
- Life and Death at Hierapolis. Norwegian excavations in a Hellenistic–Roman– Byzantine town in Asia Minor From 2007 to 2015 the University of Oslo, invited by The Italian Archaeological Mission at Hierapolis in Phrygia, conducted archaeological research in the North-East Necropolis at Hierapolis. The aim of the project was to document all visible tombs and sarcophagi of the necropolis and excavate selected tomb areas and tombs. The research, including osteological, DNA- and isotope-analyses, investigated the life of the inhabitants over a long period of time (ca. 100–1300 A.C.) with reference to tomb architecture, landscape perception, organization, entrepreneurship, ritual practices, genetic relations and origins, demography, health, sickness, diets, and individual movement patterns. Many of the aims are answered in the article, here shall only be mentioned two important discoveries: cremation has been documented as late as the 5th/6th centuries A.C., in periods of crisis perhaps used to signal pagan opposition to imposed Christian practices; the life conditions in the Roman/ Early Byzantine period were much better than in that of the Middle Byzantine period.
|
|
| 2. |
- Carrick, Richard T., et al.
(författare)
-
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
- 2024
-
Ingår i: European Heart Journal. - : OXFORD UNIV PRESS. - 0195-668X .- 1522-9645.
-
Tidskriftsartikel (refereegranskat)abstract
- Background and Aims Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of primary prevention ICDs and survival free from sustained ventricular arrhythmia (VA) in ARVC.Methods This was a retrospective analysis of ARVC patients without prior VA enrolled in clinical registries from 11 countries throughout Europe and North America. Patients were classified according to whether they received treatment in North America or Europe and were further stratified by baseline predicted VA risk into low- (<10%/5 years), intermediate- (10%-25%/5 years), and high-risk (>25%/5 years) groups. Differences in ICD implantation and survival free from sustained VA events (including appropriate ICD therapy) were assessed.Results One thousand ninety-eight patients were followed for a median of 5.1 years; 554 (50.5%) received a primary prevention ICD, and 286 (26.0%) experienced a first VA event. After adjusting for baseline risk factors, North Americans were more than three times as likely to receive ICDs {hazard ratio (HR) 3.1 [95% confidence interval (CI) 2.5, 3.8]} but had only mildly increased risk for incident sustained VA [HR 1.4 (95% CI 1.1, 1.8)]. North Americans without ICDs were at higher risk for incident sustained VA [HR 2.1 (95% CI 1.3, 3.4)] than Europeans.Conclusions North American ARVC patients were substantially more likely than Europeans to receive primary prevention ICDs across all arrhythmic risk strata. A lower rate of ICD implantation in Europe was not associated with a higher rate of VA events in those without ICDs.
|
|
